| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/22/2004 | EP1458421A1 Composition for treating contact lenses in the eye |
| 09/22/2004 | EP1458415A2 Amphiphilic compounds for pharmaceutical or cosmetic use |
| 09/22/2004 | EP1458413A2 Pharmaceutical compositions based on azetidine derivatives |
| 09/22/2004 | EP1458408A1 Liquid composition of factor vii polypeptides |
| 09/22/2004 | EP1458407A1 Liquid composition of modified factor vii polypeptides |
| 09/22/2004 | EP1458401A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 09/22/2004 | EP1458400A1 Liquid bisphosphonate formulations for bone disorders |
| 09/22/2004 | EP1458398A1 Antibiotic formulation and a method of making this formulation |
| 09/22/2004 | EP1458389A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion |
| 09/22/2004 | EP1458388A1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 09/22/2004 | EP1458387A2 Orodispersible tablets containing fexofenadine |
| 09/22/2004 | EP1458377A1 5ht4 partial agonist pharmaceutical compositions |
| 09/22/2004 | EP1458369A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 09/22/2004 | EP1458365A1 Improved polymer-lipid delivery vehicles |
| 09/22/2004 | EP1458364A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 09/22/2004 | EP1458363A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458361A2 Compositions for sustained action product delivery |
| 09/22/2004 | EP1458360A1 Pulmonary delivery of aminoglycosides |
| 09/22/2004 | EP1458359A1 Microemulsion preconcentrate |
| 09/22/2004 | EP1458358A1 Stable topical formulation of clarithromycin |
| 09/22/2004 | EP1458357A2 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 09/22/2004 | EP1458356A1 Micronized pharmaceutical or nutraceutical powder with immediate release |
| 09/22/2004 | EP1458355A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 09/22/2004 | EP1458354A1 Medicinal aerosol formulations comprising ion pair complexes |
| 09/22/2004 | EP1458353A1 Formulation dosage form for the controlled delivery of ther apeutic agents |
| 09/22/2004 | EP1458328A2 Formulations for use in medical or diagnostic procedures |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458246A1 Process for preparing chewing gum containing a nutritional supplement |
| 09/22/2004 | EP1408876A4 Zero-order prolonged release coaxial implants |
| 09/22/2004 | EP1301238B1 Needles coated with vaccine |
| 09/22/2004 | EP1289505B1 Process of producing a stable pharmaceutical composition containing micronized formoterol |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/22/2004 | EP1242047B1 Fenofibrate galenic formulations and method for obtaining same |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1196144B1 A liposome composition having resistance to freeze/thaw damage |
| 09/22/2004 | EP1173766B1 A tenascin-c isoform as a marker for neoplasias |
| 09/22/2004 | EP1152743B1 Skin sanitizing compositions |
| 09/22/2004 | EP1098646B1 Stabilized carvedilol injection solution |
| 09/22/2004 | EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment |
| 09/22/2004 | EP1064950B1 Remedies for hepatitis |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP0973806B1 Site protected protein modification |
| 09/22/2004 | EP0941121B1 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0854925B1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 09/22/2004 | EP0831767B1 Alpha hydroxyacid esters for skin aging |
| 09/22/2004 | CN1531566A Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531545A Reducing immunogenicity of fusion proteins |
| 09/22/2004 | CN1531526A Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer |
| 09/22/2004 | CN1531439A Liposome targeting of matrix metalloproteinase inhibitors |
| 09/22/2004 | CN1531436A Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
| 09/22/2004 | CN1531430A Local used composition containing antifungal agent |
| 09/22/2004 | CN1531428A Novel pharmaceutical composition for administering N-0923 |
| 09/22/2004 | CN1531427A Premixed amiodarone parenteral solution and method for making the same |
| 09/22/2004 | CN1531424A SN-38 lipid complexes and methods of use |
| 09/22/2004 | CN1531423A Preparation of low dosage medicinal composition with uniform distribution and effect |
| 09/22/2004 | CN1531422A Gene delivery formulations and methods for treatment of ischemic conditions |
| 09/22/2004 | CN1531421A Liquid pharaceutical for oral delivery |
| 09/22/2004 | CN1531420A Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof |
| 09/22/2004 | CN1531419A In-situ gel formation of pectins |
| 09/22/2004 | CN1531418A Manufacturing dissolvable dosage forms |
| 09/22/2004 | CN1531398A Animal feed supplement containing D-pantothenic acid and/or its salts, improved method for production thereof, and its use |
| 09/22/2004 | CN1530140A Vermis expelling resinate and its preparation |
| 09/22/2004 | CN1530139A Copmosition containnig dichloride sugar |
| 09/22/2004 | CN1530138A Stabilized medicine preparation form with by porous kietyoite covering flavour |
| 09/22/2004 | CN1530098A Local preparation for remitting pains and inflammation caused by nerpes virus |
| 09/22/2004 | CN1530096A Powder injection containing nonsteroidal anti-infecting chemical |
| 09/22/2004 | CN1167734C Inclusion compound of ginsenoside RG3 and hydroxypropyl-beta-cyclodextrin and its preparation and preparing process |
| 09/22/2004 | CN1167470C Controlled release tablet produced from linear water insoluble polysaccharides |
| 09/22/2004 | CN1167469C Preparation of nano particles of hydroxycamptothecine polylactate |
| 09/22/2004 | CN1167468C Preparation of transgenic compound particles of alkylated chitosan |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167461C Carbon dioxide enhancement of inhalation therapy |
| 09/22/2004 | CN1167413C Aerosol ointment compositions and preparation thereof |
| 09/22/2004 | CN1167412C Transdermal physiotherapeutic medicine gel |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794536 Method for preparation of disodium pamidronate |
| 09/21/2004 | US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment |
| 09/21/2004 | US6794384 Hydroxylation activated drug release |
| 09/21/2004 | US6794376 Delivering a therapeutic agent to said tissue; delivering a permeabilizer to the tissue; and elevating the temperature of the tissue to above normal body temperature. |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/21/2004 | US6794367 Solid preparations for oral administration of drugs relating to genes |
| 09/21/2004 | US6794364 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/21/2004 | US6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same |
| 09/21/2004 | US6794357 Compositions for inhalation |
| 09/21/2004 | US6794189 Polyampholytes for delivering polyions to a cell |
| 09/21/2004 | US6794128 Methods of selecting internalizing antibodies |
| 09/21/2004 | US6793937 Entraining active material droplets in a hydrophilic matrix inside a hydrogel, suspending in a solution, applying to a substrate and allowing to dehydrate |
| 09/21/2004 | US6793936 Delivers an active ingredient in a pulsed or bimodal manner. |
| 09/21/2004 | US6793934 Solid oral dosage form |
| 09/21/2004 | US6793933 Dietary supplements for enhancing the immune system |
| 09/21/2004 | US6793929 Preparations of the w/o emulsion type with an increased water content, comprising moderately polar lipids and silicone emulsifiers and, if desired, cationic polymers |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793827 Method and device for preparing a medical fluid |